 | Up a level |
2016
Kim, Dong-Wan, Mehra, Ranee, Tan, Daniel S. W., Felip, Enriqueta, Chow, Laura Q. M., Camidge, D. Ross, Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J., Solomon, Benjamin J., Wolf, Juergen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey 
ORCID: 0000-0002-2603-7296, Santoro, Armando ORCID: 0000-0003-1709-9492, Sutradhar, Santosh, Li, Siyu, Szczudlo, Tomasz, Yovine, Alejandro and Shaw, Alice T.
(2016).
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial.
Lancet Oncol., 17 (4).
S. 452 - 464.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488